Your browser doesn't support javascript.
loading
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
Prabhu, Vimalanand S; Cornely, Oliver A; Golan, Yoav; Dubberke, Erik R; Heimann, Sebastian M; Hanson, Mary E; Liao, Jane; Pedley, Alison; Dorr, Mary Beth; Marcella, Stephen.
Afiliação
  • Prabhu VS; Economic and Data Sciences, Center for Real World and Observational Studies, Merck & Co., Inc., Kenilworth, New Jersey.
  • Cornely OA; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Department of Internal Medicine, Clinical Trials Centre Cologne, University of Cologne, Germany.
  • Golan Y; Department of Medicine, Geographic Medicine and Infectious Diseases, Tufts University School of Medicine, Boston, Massachusetts.
  • Dubberke ER; Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri.
  • Heimann SM; Department of Internal Medicine, University Hospital of Cologne, Germany.
  • Hanson ME; Global Scientific and Medical Publications, Infectious Diseases & Vaccines.
  • Liao J; Statistical Programming for Center for Outcomes Research Excellence.
  • Pedley A; Biostatistics, Late Development Statistics.
  • Dorr MB; Clinical Research, Infectious Diseases, and.
  • Marcella S; Outcomes Research, Center for Outcomes Research Excellence, Acute Hospital & Specialty Care, Merck & Co., Inc., Kenilworth, New Jersey.
Clin Infect Dis ; 65(7): 1218-1221, 2017 10 01.
Article em En | MEDLINE | ID: mdl-30060024

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium / Anticorpos Neutralizantes / Antibacterianos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium / Anticorpos Neutralizantes / Antibacterianos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article